ALAZNE
BUSTINZA TXERTUDI
Hospital de Cruces
Barakaldo, EspañaPublications in collaboration with researchers from Hospital de Cruces (3)
2021
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130
-
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units
European Journal of Pediatrics, Vol. 180, Núm. 4, pp. 1169-1176
2015
-
Drug interactions with sunitinib
Journal of Oncology Pharmacy Practice, Vol. 21, Núm. 1, pp. 52-66